Intellia Therapeutics (NTLA) Research & Development (2015 - 2026)
Intellia Therapeutics (NTLA) recorded Research & Development of $82.6 million in Q2 2026, down 14.9% from $97.04 million a year earlier but up 2.3% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Research & Development (2015 - 2026) Analysis & Trends
On a TTM basis, Intellia Therapeutics' Research & Development came in at $346.73 million as of Jun 30, 2026, down 22.2% year-over-year; for FY2025, it was $388.86 million, down 16.6% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 20.9% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $466.31 million in FY2024 (+7.2%), $435.07 million in FY2023 (+3.6%), $419.98 million in FY2022 (+82.8%) and $229.81 million in FY2021 (+52.8%).
- Quarterly Research & Development has ranged from $60.49 million in Q3 2021 to $133.1 million in Q1 2022 over the past five years.
- On a year-over-year basis, Research & Development has declined for six consecutive quarters, with an average decline of 11.3% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 238.9% in Q1 2022, against a decline of 27.0% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $80.74 million (Q1 2026), $88.65 million (Q4 2025) and $94.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Intellia Therapeutics | 1.60 Bn | 1.60 Bn | - | 82.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.60 Mn |
| Mar 31, 2026 | 80.74 Mn |
| Dec 31, 2025 | 88.65 Mn |
| Sep 30, 2025 | 94.75 Mn |
| Jun 30, 2025 | 97.04 Mn |
| Mar 31, 2025 | 108.43 Mn |
| Dec 31, 2024 | 116.88 Mn |
| Sep 30, 2024 | 123.38 Mn |
| Jun 30, 2024 | 114.21 Mn |
| Mar 31, 2024 | 111.85 Mn |
| Dec 31, 2023 | 108.98 Mn |
| Sep 30, 2023 | 113.70 Mn |
| Jun 30, 2023 | 115.28 Mn |
| Mar 31, 2023 | 97.12 Mn |
| Dec 31, 2022 | 100.03 Mn |
| Sep 30, 2022 | 96.65 Mn |
| Jun 30, 2022 | 90.20 Mn |
| Mar 31, 2022 | 133.10 Mn |
| Dec 31, 2021 | 71.16 Mn |
| Sep 30, 2021 | 60.49 Mn |
API Access
Intellia Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();